ATE509932T1 - Polymorphe form von 6-(4-chlorphenyl)-2,2- - Google Patents
Polymorphe form von 6-(4-chlorphenyl)-2,2-Info
- Publication number
- ATE509932T1 ATE509932T1 AT06723557T AT06723557T ATE509932T1 AT E509932 T1 ATE509932 T1 AT E509932T1 AT 06723557 T AT06723557 T AT 06723557T AT 06723557 T AT06723557 T AT 06723557T AT E509932 T1 ATE509932 T1 AT E509932T1
- Authority
- AT
- Austria
- Prior art keywords
- ppm
- chlorphenyl
- polymorphous form
- pyrrolizin
- adamantane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005012971A DE102005012971A1 (de) | 2005-03-21 | 2005-03-21 | Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
| PCT/EP2006/002539 WO2006100019A1 (en) | 2005-03-21 | 2006-03-20 | Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE509932T1 true ATE509932T1 (de) | 2011-06-15 |
Family
ID=36568591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06723557T ATE509932T1 (de) | 2005-03-21 | 2006-03-20 | Polymorphe form von 6-(4-chlorphenyl)-2,2- |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8034837B2 (de) |
| EP (1) | EP1861404B1 (de) |
| JP (1) | JP5009280B2 (de) |
| CN (1) | CN101160311B (de) |
| AT (1) | ATE509932T1 (de) |
| AU (1) | AU2006226625B2 (de) |
| CA (1) | CA2602224A1 (de) |
| DE (1) | DE102005012971A1 (de) |
| ES (1) | ES2367274T3 (de) |
| MX (1) | MX2007011455A (de) |
| PL (1) | PL1861404T3 (de) |
| PT (1) | PT1861404E (de) |
| RU (1) | RU2007138924A (de) |
| SI (1) | SI1861404T1 (de) |
| WO (1) | WO2006100019A1 (de) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260451A (en) | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
| DE3915450A1 (de) | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
| DE4419247A1 (de) | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie |
| DE4419246A1 (de) | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie |
| DE4419315A1 (de) | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie |
| CA2246265A1 (en) * | 1996-02-13 | 1997-08-21 | G.D. Searle & Co. | Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors |
| SK286608B6 (sk) | 2000-01-28 | 2009-02-05 | Merckle Gmbh | Spôsob prípravy kyseliny 6-(4-chlórfenyl)-2,2-dimetyl-7-fenyl- 2,3-dihydro-1H-pyrolizin-5-yl octovej |
| DE10141285A1 (de) | 2001-08-23 | 2003-03-27 | Merckle Gmbh | Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
| PL1745791T3 (pl) * | 2003-05-07 | 2013-11-29 | Osteologix As | Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu |
-
2005
- 2005-03-21 DE DE102005012971A patent/DE102005012971A1/de not_active Withdrawn
-
2006
- 2006-03-20 CN CN2006800091574A patent/CN101160311B/zh not_active Expired - Fee Related
- 2006-03-20 PT PT06723557T patent/PT1861404E/pt unknown
- 2006-03-20 MX MX2007011455A patent/MX2007011455A/es active IP Right Grant
- 2006-03-20 AU AU2006226625A patent/AU2006226625B2/en not_active Ceased
- 2006-03-20 ES ES06723557T patent/ES2367274T3/es active Active
- 2006-03-20 CA CA002602224A patent/CA2602224A1/en not_active Abandoned
- 2006-03-20 US US11/886,933 patent/US8034837B2/en not_active Expired - Fee Related
- 2006-03-20 AT AT06723557T patent/ATE509932T1/de not_active IP Right Cessation
- 2006-03-20 SI SI200631089T patent/SI1861404T1/sl unknown
- 2006-03-20 JP JP2008502304A patent/JP5009280B2/ja not_active Expired - Fee Related
- 2006-03-20 EP EP06723557A patent/EP1861404B1/de not_active Not-in-force
- 2006-03-20 WO PCT/EP2006/002539 patent/WO2006100019A1/en active Application Filing
- 2006-03-20 RU RU2007138924/04A patent/RU2007138924A/ru not_active Application Discontinuation
- 2006-03-20 PL PL06723557T patent/PL1861404T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2367274T3 (es) | 2011-11-02 |
| RU2007138924A (ru) | 2009-04-27 |
| PL1861404T3 (pl) | 2011-12-30 |
| MX2007011455A (es) | 2007-12-06 |
| DE102005012971A1 (de) | 2006-09-28 |
| AU2006226625B2 (en) | 2011-04-21 |
| US8034837B2 (en) | 2011-10-11 |
| PT1861404E (pt) | 2011-09-01 |
| JP2008535809A (ja) | 2008-09-04 |
| EP1861404A1 (de) | 2007-12-05 |
| AU2006226625A1 (en) | 2006-09-28 |
| CN101160311A (zh) | 2008-04-09 |
| CN101160311B (zh) | 2010-11-24 |
| US20090209610A1 (en) | 2009-08-20 |
| SI1861404T1 (sl) | 2011-11-30 |
| CA2602224A1 (en) | 2006-09-28 |
| EP1861404B1 (de) | 2011-05-18 |
| JP5009280B2 (ja) | 2012-08-22 |
| WO2006100019A1 (en) | 2006-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066375A (es) | Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
| ECSP066376A (es) | FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
| CR8249A (es) | Forma cristalina gamma del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen | |
| EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
| WO2006114401A3 (en) | Novel cyclic amines | |
| EA200870460A1 (ru) | Производные циклогексилпиразол-лактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1 | |
| DK2049475T3 (da) | Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1 | |
| EA200870462A1 (ru) | Производные бифениламидлактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1 | |
| NI200600240A (es) | FORMA CRISTALINA Delta-d CLORHIDRATO DE LA IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN, Y LAS COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
| DK1893587T3 (da) | Fremgangsmåde til fremstilling af dihydroquinazoliner | |
| TN2011000245A1 (en) | Organic compounds | |
| NO20070445L (no) | Pyrimidinderivater. | |
| EA201070238A1 (ru) | Соединения пиримидина | |
| DK2035379T3 (da) | Inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1 | |
| BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
| GB0625648D0 (en) | Compounds | |
| TW200833324A (en) | Sulfonamide derivatives | |
| EA201070423A1 (ru) | Диарильные соединения оксадиазолов | |
| CY1106902T1 (el) | Κρυσταλλικη μορφη μηλεϊνικης ασεναπινης | |
| GEP20135780B (en) | Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents | |
| EA200701810A1 (ru) | Производное изоксазолина и новый способ его получения | |
| TW200716568A (en) | 1H-quinazoline-2,4-diones | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| DE602006009789D1 (de) | Acetylenderivate | |
| NO20085317L (no) | Imidazoazepinonforbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |